Balaashwin Babu

Mr. Balaashwin Babu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2021 in WIREs Nanomedicine and Nanobiotechnology
Verified
Journal Article
Closed access
PDF file
Elayaraja KolanthaiElayaraja Kolanthai
Elayaraja Kolanthai
YFYifei Fu
Yifei Fu
UKUdit Kumar
Udit Kumar
BBBalaashwin Babu
Balaashwin Babu
AVArchitha Krishnammal Venkatesan
Architha Krishnammal Venkatesan
SSSudipta Seal
Sudipta Seal

16 May 2023 in WIREs Nanomedicine and Nanobiotechnology
Verified
Journal Article
Closed access
BBBalaashwin Babu
Balaashwin Babu
SPShreya Pawar
Shreya Pawar
AMAgastya Mittal
Agastya Mittal
Elayaraja KolanthaiElayaraja Kolanthai
Elayaraja Kolanthai
CNCraig Neal
Craig Neal
SSSudipta Seal
Sudipta Seal

30 October 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
BBBalaashwin Babu
Balaashwin Babu
SSSamantha Archer Stoltz
Samantha Archer Stoltz
AMAgastya Mittal
Agastya Mittal
SPShreya Pawar
Shreya Pawar
Elayaraja KolanthaiElayaraja Kolanthai
Elayaraja Kolanthai
SSSudipta Seal
Sudipta Seal
Nanotechnology has expanded what can be achieved in our approach to cancer treatment. The ability to produce and engineer functional nanoparticle formulations to elicit higher incidences of tumor cell radiolysis has resulted in substantial improvements in cancer cell eradication while also permitting multi-modal biomedical functionalities. These radiosensitive nanomaterials utilize material characteristics, such as radio-blocking/absorbing high-Z atomic number elements, to mediate localized effects from therapeutic irradiation. These materials thereby allow subsequent scattered or emitted radiation to produce direct (e.g., damage to genetic materials) or indirect (e.g., protein oxidation, reactive oxygen species formation) damage to tumor cells. Using nanomaterials that activate under certain physiologic conditions, such as the tumor microenvironment, can selectively target tumor cells. These characteristics, combined with biological interactions that can target the tumor environment, allow for localized radio-sensitization while mitigating damage to healthy cells. This review explores the various nanomaterial formulations utilized in cancer radiosensitivity research. Emphasis on inorganic nanomaterials showcases the specific material characteristics that enable higher incidences of radiation while ensuring localized cancer targeting based on tumor microenvironment activation. The aim of this review is to guide future research in cancer radiosensitization using nanomaterial formulations and to detail common approaches to its treatment, as well as their relations to commonly implemented radiotherapy techniques.

26 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
BBBalaashwin Babu
Balaashwin Babu
SSSamantha Archer Stoltz
Samantha Archer Stoltz
AMAgastya Mittal
Agastya Mittal
SPShreya Pawar
Shreya Pawar
Elayaraja KolanthaiElayaraja Kolanthai
Elayaraja Kolanthai
SSSudipta Seal
Sudipta Seal
: Nanotechnology has expanded what can be achieved in our approach to cancer treatment. The ability to produce and engineer functional nanoparticle formulations to elicit higher incidences of tumor cell radiolysis has resulted in substantial improvements in cancer cell eradication while also permitting multi-modal biomedical functionalities. These radiosensitive nanomaterials utilize material characteristics, such as radio- blocking/absorbing high-Z atomic number elements, to mediate localized effects from therapeutic irradiation. These materials thereby allow for subsequent scattered or emitted radiation to produce direct (e.g., damage to genetic materials) or indirect (e.g., protein oxidation, reactive oxygen species formation) damage to tumor cells. Using nanomaterials that activate under certain physiologic conditions such as the tumor micro-environment can selectively target tumor cells. These characteristics combined with biological interactions that can target the tumor environment allow for localized, radio-sensitization while mitigating damage to healthy cells. This review explores the various nanomaterial formulations utilized in cancer radiosensitivity research. Emphasis on inorganic nanomaterials showcase the specific material characteristics that enable higher incidences of radiation while ensuring localized cancer targeting based on tumor micro-environment activation. The aim of this review is to guide future research in cancer radiosensitization using nanomaterial formulations and to detail common approaches to radiosensization, as well their relations to commonly implemented radiotherapy techniques.